A detailed history of Bank Of Montreal transactions in Staar Surgical CO stock. As of the latest transaction made, Bank Of Montreal holds 6,090 shares of STAA stock, worth $149,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,090
Previous 6,728 9.48%
Holding current value
$149,814
Previous $320,000 29.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$29.97 - $47.42 $19,120 - $30,253
-638 Reduced 9.48%
6,090 $226,000
Q2 2024

Aug 14, 2024

BUY
$38.07 - $52.25 $9,593 - $13,167
252 Added 3.89%
6,728 $320,000
Q1 2024

May 13, 2024

BUY
$27.67 - $39.61 $179,190 - $256,514
6,476 New
6,476 $247,000
Q3 2023

Nov 01, 2023

BUY
$39.39 - $58.12 $81,104 - $119,669
2,059 Added 35.6%
7,842 $315,000
Q2 2023

Aug 02, 2023

SELL
$50.45 - $72.82 $20,987 - $30,293
-416 Reduced 6.71%
5,783 $304,000
Q1 2023

Jun 13, 2024

BUY
$51.25 - $79.34 $94,915 - $146,937
1,852 Added 28.6%
8,328 $532,000
Q4 2022

Feb 01, 2023

SELL
$46.82 - $76.2 $198,189 - $322,554
-4,233 Reduced 40.58%
6,199 $300,000
Q3 2022

Nov 10, 2022

SELL
$70.55 - $111.58 $3.86 Million - $6.1 Million
-54,691 Reduced 83.98%
10,432 $848,000
Q2 2022

Aug 11, 2022

BUY
$50.24 - $80.48 $2.85 Million - $4.57 Million
56,795 Added 681.98%
65,123 $4.98 Million
Q1 2022

May 12, 2022

SELL
$57.98 - $93.5 $2,435 - $3,927
-42 Reduced 0.5%
8,328 $688,000
Q4 2021

Feb 11, 2022

BUY
$88.02 - $127.79 $31,951 - $46,387
363 Added 4.53%
8,370 $786,000
Q3 2021

Nov 12, 2021

BUY
$122.75 - $162.68 $123,977 - $164,306
1,010 Added 14.43%
8,007 $1.03 Million
Q2 2021

Aug 12, 2021

BUY
$105.76 - $154.96 $740,002 - $1.08 Million
6,997 New
6,997 $1.08 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.18B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.